发明名称 Alirocumab ou un dérivé pharmaceutiquement acceptable de celui-ci (PRALUENT)
摘要 Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
申请公布号 LU93180(I2) 申请公布日期 2016.10.18
申请号 LU20160093180C 申请日期 2016.08.18
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址